Weekly News Roundup – Neuro Breakthroughs, Biosimilar Reform, and an Obesity Drug Showdown

episode

tHEORetically Speaking not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from tHEORetically Speaking

From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap 11 min · 13 Jul 2026

All episodes from tHEORetically Speaking →

Report any issue

Source

Recorded31 Oct 2025

Publisherfeeds.buzzsprout.com

Handlerec:11539509

Show notes

This week’s tHEORetically Speaking News Roundup covers Evotec and Bristol Myers Squibb’s progress in developing next-generation therapies for neurodegenerative diseases, the FDA’s game-changing move to streamline biosimilar approvals and lower drug costs, and Novo Nordisk’s bold $6.5B counteroffer to outbid Pfizer for Metsera in the obesity treatment race.Tune in for this concise recap of the top stories shaping HEOR, RWE, and Market Access this week.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.